Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myocarditis IV: Nursing Management

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...

Nephrotic Syndrome II : Assessment and Medical Management

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

Pericarditis III: Medical Management

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages.

Neuro-oncology·2019

Same author

Telerheumatology: The VA Experience.

Southern medical journal·2018

Same author

Competency Skills Assessment: Successes and Areas for Improvement Identified During Collaboration Between Informaticists and a National Organization.

Studies in health technology and informatics·2016

Same author

Operationalizing the TANIC and NICA-L3/L4 Tools to Improve Informatics Competencies.

Studies in health technology and informatics·2016

Same author

Why nurses need to understand nursing informatics.

AORN journal·2014

Same author

A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma.

Neuro-oncology·2010

Search research articles

Related Experiment Video

Updated: May 17, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

Evaluation and management of polymyositis.

Kathy Hunter¹, Michael G Lyon

¹RNP Veterans Health, Rheumatology and Hematology, Rheumatology Section, VA Palo Alto Health Care System, Stanford University School of Medicine, USA.

Indian Journal of Dermatology

|November 1, 2012

Summary

Polymyositis (PM) is an autoimmune disorder causing muscle inflammation and weakness, primarily affecting proximal muscles. Treatment with corticosteroids and immunosuppressants improves function, with a 95% 5-year survival rate.

Keywords:

Polymyositis diagnostic evaluation medications physical therapy treatment

Related Experiment Videos

Last Updated: May 17, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

Area of Science:

Neurology
Rheumatology
Immunology

Background:

Polymyositis (PM) is an idiopathic inflammatory myopathy characterized by inflammatory infiltrates in skeletal muscle.
The primary clinical feature of PM is proximal muscle weakness, with an unknown autoimmune etiology.
PM typically affects individuals aged 50-70, is more prevalent in females and Black individuals, with an overall prevalence of 1 in 100,000.

Purpose of the Study:

To describe the clinical manifestations, associations, and treatment outcomes of Polymyositis.
To highlight the diagnostic and therapeutic challenges in managing this autoimmune muscle disease.

Main Methods:

Literature review of Polymyositis (PM) and related inflammatory myopathies.
Analysis of clinical presentation, diagnostic criteria, and therapeutic strategies for PM.

Main Results:

PM presents with proximal muscle weakness, potentially leading to dysphagia, ventilatory compromise, and cardiac issues.
Associated conditions include malignancies and other rheumatic diseases; drug- or virus-induced myopathies are also noted.
Corticosteroids and immunosuppressants are primary treatments, aiming to improve strength and function.

Conclusions:

Polymyositis is a serious autoimmune condition requiring long-term management.
Therapeutic interventions significantly improve patient outcomes, with a high 5-year survival rate.
Residual muscle weakness may persist in a portion of treated patients.